Quantitative profiling of progesterone metabolites for the prediction of spontaneous preterm delivery

Patent metadata

Field	Value
Publication number	US-11280795-B2
Application number	US-201716099017-A
Country	US
Kind code	B2
Filing date	May 3, 2017
Priority date	May 5, 2016
Publication date	Mar 22, 2022
Grant date	Mar 22, 2022

Abstract

Disclosed are methods for identifying a pregnant female who is susceptible to spontaneous preterm delivery. In particular, disclosed are methods for identifying a pregnant female who is susceptible to spontaneous preterm delivery based on ratios of steroids in samples obtained from the pregnant female.

First claim

What is claimed is:

1. A method of detecting a ratio of deoxycorticosterone (DOC) to 16α-hydroxyprogesterone (16αOHP) in a pregnant female, the method comprising:
obtaining a sample from the pregnant female;
detecting a concentration of DOC in the sample;
detecting a concentration of 16αOHP; and
detecting a ratio of DOC/16αOHP.

2. A method for identifying a pregnant female as being susceptible to spontaneous preterm delivery, the method comprising:
obtaining a sample from the pregnant female;
determining a concentration of a first steroid selected from the group consisting of deoxycorticosterone, corticosterone, 18-hydroxycorticosterone, aldosterone, deoxycortisol, cortisol and combinations thereof in the sample;
determining a concentration of at least a second steroid, wherein the second steroid is different from the first steroid;
calculating a ratio of the first steroid and the at least second steroid; and
identifying the pregnant female as being susceptible to spontaneous preterm delivery when the ratio in the sample is reduced below a threshold value.

3. The method of claim 2 , wherein the second steroid is selected from the group consisting of progesterone, 16α-hydroxyprogesterone, 6β-hydroxyprogesterone, 6α-hydroxyprogesterone, 17-hydroxyprogesterone, 11-deoxycortisol, cortisol, 11-deoxycorticosterone, 17-deoxycortisol, androstenedione, testosterone, estradiol, 20α-dihydroprogesterone, 17α,20α-dihydroxyprogesterone, isopregnanolone, and combinations thereof.

4. The method of claim 2 , further comprising determining a concentration of a biomarker selected from the group consisting of insulin-like growth factor binding protein 4, sex-hormone binding globulin, lipopolysaccharide-binding protein (LBP), lipopolysaccharide-binding protein (LBP) precursor, prothrombin (THRB), complement component C5 (C5 or CO5), plasminogen (PLMN), complement component C8 gamma chain (C8G or CO8G), Complement factor B, Ectonucleotide pyrophosphatase/phosphodiesterase family member 2, Gelsolin, N-acetylmuramoyl-L-alanine amidase, N-acetylmuramoyl-L-alanine amidase precursor, Hyaluronan-binding protein 2, BPI fold-containing family B member 1, complement component C8 alpha chain, apolipoprotein A-II, Ectonucleotide pyrophosphatase/phosphodiesterase family member 2, profiling-1, pro-neuropeptide Y, complement component C8 beta chain, coagulation factor XIIII B chain, N-acetylmuramoyl-L-alanine amidase, inter-alpha-trypsin inhibitor heavy chain H4, inter-alpha-trypsin inhibitor heavy chain H3 preproprotein, leucyl-cystinyl aminopeptidase, alpha-2-HS-glycoprotein, 5′-AMP-activated protein kinase subunit gamma-3, afamin precursor, alpha-1-antichymotrypsin precursor, alpha-1B-glycoprotein precursor, alpha-2-antiplasmin isoform a precursor, alpha-2-HS-glycoprotein preproprotein, alpha-2-HS-macroglobulin precursor, angiotensinogen preproprotein, antithrombin-III precursor, apolipoprotein A-II preproprotein, apolipoprotein A-IV precursor, apolipoprotein B-100 precursor, apolipoprotein C-I precursor, apolipoprotein C-II precursor, apolipoprotein C-III precursor, apolipoprotein E precursor, ATP-binding cassette sub-family D member 4, ATP-binding cassette sub-family F member 3, beta-2-glycoprotein 1 precursor, beta-Ala-His dipeptidase precursor, biotinidase precursor, carboxypeptidase B2 preproprotein, carboxypeptidase N catalytic chain precursor, carboxypeptidase N subunit 2 precursor, catalase, ceruloplasmin precursor, cholinesterase precursor, clusterin preproprotein, coagulation factor IX preproprotein, coagulation factor VII isoform a, coagulation factor VII isoform a preproprotein, coagulation factor X preproprotein, coagulation factor XIII B chain, coiled-coil domain-containing protein 13, complement C1q subcomponent subunit A precursor, complement C1q subcomponent subunit B precursor, complement C1q subcomponent subunit C precursor, complement C1r subcomponent precursor, complement C1s subcomponent precursor, complement C2 isoform 3, complement C3 precursor, complement C4-A isoform 1, complement C5 preproprotein, component C6 precursor, component C7 precursor, component C8 alpha chain precursor, complement component C9 precursor, complement factor B preproprotein, complement factor H isoform a precursor, complement factor H isoform b precursor, complement factor H H-related protein 1 precursor, complement factor I preproprotein, conserved oligomeric Golgi complex subunit 6 isoform, corticosteroid-binding globulin precursor, C-reactive protein precursor, dopamine beta-hydroxylase precursor, double-stranded RNA-specific editase B2, dual oxidase 2 precursor, FERM domain-containing protein 8, fetuin-B precursor, ficolin-3 isoform 1 precursor, gastric intrinsic factor precursor, gelsolin isoform d, glutathione peroxidase 3 precursor, hemopexin precursor, heparin cofactor 2 precursor, hepatocyte cell adhesion molecule precursor, hepatocyte growth factor activator preproprotein, histidine-rich glycoprotein precursor, hyaluronan-binding protein 2 isoform 1 preproprotein, inactive caspase-12 insulin-degrading enzyme isoform 1, insulin-like growth factor-binding protein complex acid labile subunit isoform 2 precursor, inter-alpha-trypsin inhibitor heavy chain H1 isoform a precursor, inter-alpha-trypsin inhibitor heavy chain H2 precursor, inter-alpha-trypsin inhibitor heavy chain H4 isoform 1 precursor, kallistatin precursor, kininogen-1 isoform 2 precursor, leucine-rich alpha-2-glycoprotein precursor, lumican precursor, m7GpppX diphosphatase, matrix metalloproteinase-19 isoform 1 preproprotein, MBT domain-containing protein 1, monocyte differentiation antigen CD14 precursor, pappalysin-1 preproprotein, phosphatidylinositol-glycan-specific phospholipase D precursor, pigment epithelium-derived factor precursor, plasma kallikrein preproprotein, plasma protease C1 inhibitor precursor, plasminogen isoform 1 precursor, platelet basic protein preproprotein, platelet glycoprotein V precursor, pregnancy zone protein precursor, pregnancy-specific beta-1-glycoprotein 5, pregnancy-specific beta-1-glycoprotein 5 precursor, pregnancy-specific beta-1-glycoprotein 6, pregnancy-specific beta-1-glycoprotein 6 precursor, pregnancy-specific beta-1-glycoprotein 7, pregnancy-specific beta-1-glycoprotein 8, pregnancy-specific beta-1-glycoprotein 9, pregnancy-specific beta-1-glycoprotein 11, pregnancy-specific beta-1-glycoprotein 2, pregnancy-specific beta-1-glycoprotein 3, pregnancy-specific beta-1-glycoprotein 4, progesterone-induced-blocking factor 1, protein AMBP preproprotein, protein CBFA2T2 isoform MTGR1b, protein FAM98C, protein NLRC3, protein Z-dependent protease inhibitor precursor, prothrombin preproprotein, putative hydroxypyruvate isomerase isoform 1, ras-like protein family member 10A precursor, ras-related GTP-binding protein A, retinol-binding protein 4 precursor, sex hormone-binding globulin isoform 1 precursor, sex hormone-binding globulin isoform 4 precursor, signal transducer and activator of transcription 2, spectrin beta chain non-erythrocytic 1, stabilin-1 precursor, succinate semialdehyde dehydrogenase mitochondrial, tetranectin precursor, THAP domain-containing protein 6, thyroxine-binding globulin precursor, tripartite motif-containing protein 5, vitamin D-binding protein isoform 1 precursor, vitronectin precursor, zinc finger protein 142, attractin isoform 2 preproprotein, transforming growth factor-beta-induced protein ig-h3 precursor, transthyretin precursor, uncharacterized protein C3orf20, beta-2-microglobulin precursor, bone marrow proteoglycan isoform 1 preproprotein, chorionic gonadotropin beta polypeptide 8 precursor, chorionic somatomammotropin hormone 2 isoform 2 precursor, macrophage colony-stimulating factor 1 receptor precursor, zinc-alpha-2-glycoprotein precursor, PAN-PSG, complement component C6 precursor, EGF-containing fibulin-like extracellular matrix protein 1, di

Assignees

• Univ Indiana Res & Tech Corp

Inventors

• Patil Avinash Shivaputrappa

Classifications

• C07J1/0011

  substituted in position 17 by a keto group · CPC title

• C07J7/0045

  not substituted in position 16 · CPC title

• G01N33/74

  involving hormones {or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors} · CPC title

• G01N2333/723

  Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor · CPC title

• C07J7/002

  not substituted in position 16 · CPC title